Medicare Advantage Myths That Could Cost You in 2025 From “$0 premium” plans to shrinking networks, not everything in the brochure tells the full story. Here’s how to separate fact from fiction this open enrollment.
getty
Every fall, the…

Medicare Advantage Myths That Could Cost You in 2025 From “$0 premium” plans to shrinking networks, not everything in the brochure tells the full story. Here’s how to separate fact from fiction this open enrollment.
getty
Every fall, the…

OpenEvidence’s Daniel Nadler
Mauricio Candela for Forbes

Scientists have developed a promising cancer therapy that uses LED light and ultra-thin flakes of tin to eliminate cancer cells while protecting healthy tissue. Unlike traditional chemotherapy and other invasive treatments, this new method avoids…

A major clinical study by the ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) has found that an immune-based cancer drug may help reduce the spread of Merkel cell carcinoma, a rare but aggressive type of skin cancer, when used soon after surgery….

Ultra-endurance athletes triumph over staggering distances and harsh conditions. But one of their toughest foes may be their own metabolic ceiling.
By scrutinizing a group of top-tier long-haul athletes, scientists have now helped…

People who had lost their sight have regained the ability to read after receiving an innovative electronic eye implant paired with augmented-reality glasses, according to a clinical trial involving researchers from UCL (University College London)…

MUNICH, GERMANY – OCTOBER 16: Lena Oberdorf of FC Bayern München looks on prior to the UEFA Women’s Champions League 2025/26 league phase match between FC Bayern München and Juventus FC at FCB Campus on October 16, 2025 in Munich, Germany….

Running offers a wide range of advantages for both body and mind. It can protect against disease, improve mood, and even slow down the body’s natural aging process.
Yet about 31% of adults still don’t get enough physical activity, including…

Since 2015, dermatologists have advised many patients with a history of skin cancer to consider taking nicotinamide, a form of vitamin B3. That recommendation was based on a clinical trial involving 386 participants, which found that those who…

The European Medicines Agency has once again recommended to prolong the marketing suspension of Oxbryta (Voxelotor), a drug that treats sickle cell disease (SCD). The Pfizer therapy was first suspended last year, when emerging data from clinical…